<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="44846" whole_study_id="44846" phs="002683" v="1" p="1" createDate="2021-10-29T08:43:08-05:00" completedByGPADate="2021-10-29T12:42:20-05:00" modDate="2022-04-06T22:05:28-05:00" maxParentChildStudyModDate="2022-04-06T22:05:28-05:00" handle="CheckpointInhibitionMelanoma" num_participants="67"><StudyInfo accession="phs002683.v1.p1" parentAccession="phs002683.v1.p1"><BioProject id="PRJNA776381" entrez_id="776381" type="bp_admin_access"/><BioProject id="PRJNA776382" entrez_id="776382" type="bp_data_submission"/><StudyNameEntrez>Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma</StudyNameEntrez><StudyTypes2 calculated="No"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="Yes" other_value="individual sequencing"/></StudyTypes2><StudyTypes><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>U54CA224068</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="NHACOHEN" aid="2" auth="eRA" login="NHACOHEN" fname="Nir" mname="" lname="Hacohen" email="nhacohen@broadinstitute.org"><Role allow_direct_access="true">PI</Role><Organization>MASSACHUSETTS INSTITUTE OF TECHNOLOGYBROAD INSTITUTE, INC.MASSACHUSETTS GENERAL HOSPITAL</Organization></Person><Person nedid="0010156177" aid="1" auth="cit" login="ivyp" fname="Susan" mname="Percy" lname="Ivy" email="ivyp@ctep.nci.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="SADEFELDMAN" aid="2" auth="eRA" login="SADEFELDMAN" fname="Moshe" mname="" lname="Sade-Feldman" email="MSADE-FELDMAN@mgh.harvard.edu"><Role>PI_ASSIST</Role><Organization>MASSACHUSETTS GENERAL HOSPITAL</Organization></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011552437" aid="1" auth="cit" login="jawang" fname="Zhen" mname="Yuan" lname="Wang" email="zhen.wang@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011059039" aid="1" auth="cit" login="withersk" fname="Kim" mname="Juanita" lname="Witherspoon" email="kw265c@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>First and foremost, we would like to express our deep gratitude to the patients and their families for making this study possible. We thank the Genomics Platform of the Broad Institute of Harvard and MIT for the whole exome and bulk RNA sequencing performed in this study. This study was supported by grants from Broad Next-10 (N.H), Cancer Research Institute (Clinic and Laboratory Integration Program, N.H), Adelson Medical Research Foundation (N.H), U54CA224068 (N.H), the David P. Ryan, MD, Chair funded by a gift from Arthur, Sandra and Sarah Irving (N.H.), the Paul C. Zamecnick, MD, Chair in Oncology at MGH (G.G), NIH/NHGRI 5U54HG003067 (S.G), and NIH/NCI R01CA208756 (N.H). We also thank the following grants for their support: Tosteson &amp; Fund for Medical Discovery fellowships (M.S.F) and NIH 1T32CA207021-01 (J.H.C)</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="4876" CGType="cg_class_DS" title="Disease-Specific (Melanoma and Skin Cancer Research, MDS)" name="DS-MSC-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Melanoma and Skin Cancer Research.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><AdditionalEmails><Email>CTEPDAR@nih.gov</Email></AdditionalEmails></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>